Sugi Predict

Sugi Predict / Compounds / SCHEMBL14768619

SCHEMBL14768619

SCHEMBL14768619

Cc1cc(C)cc(Sc2ccc(C#N)cc2CN2CCCCC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MAPT P10636 1/20 0.38
▸ USP14 P54578 3/20 0.38
▸ HRH3 Q9Y5N1 3/20 0.37
▸ CACNB4 O00305 2/20 0.36
▸ CACNA1A O00555 2/20 0.36
▸ CACNA1G O43497 2/20 0.36
▸ CACNG3 O60359 2/20 0.36
▸ CACNA1F O60840 2/20 0.36
▸ CACNA1H O95180 2/20 0.36
▸ CACNB3 P54284 2/20 0.36
▸ CACNA2D1 P54289 2/20 0.36
▸ CACNG7 P62955 2/20 0.36
▸ CACNA1B Q00975 2/20 0.36
▸ CACNA1D Q01668 2/20 0.36
▸ CACNB1 Q02641 2/20 0.36
▸ CACNG1 Q06432 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14768607 0.92 CHRNA7 (0.39) CHRNA7L3MBTL1NPSR1MAPK1MAPT
SCHEMBL14768634 0.88 ADORA2A (0.35) CHRNA7HRH3DRD2DRD4DRD3
SCHEMBL14768592 0.88 CYP2A13 (0.40) NPSR1HRH3DRD2DRD4DRD3
SCHEMBL14768590 0.87 ACHE (0.41) NPSR1HRH3DRD2DRD4DRD3
SCHEMBL14768599 0.86 KMT2A (0.41) CHRNA7DRD2DRD4DRD3ALDH1A1
SCHEMBL14768596 0.81 L3MBTL1 (0.38) L3MBTL1DRD2DRD4DRD3ALDH1A1
SCHEMBL14039265 0.81 SLC6A4 (0.42) HRH3ALDH1A1KDM1AKMT2A
SCHEMBL14768623 0.81 CYP2A13 (0.40) L3MBTL1MAPK1MAPTHRH3DRD2
SCHEMBL14768585 0.80 KDM1A (0.38) USP14HRH3DRD2DRD4DRD3
SCHEMBL14768591 0.80 ACHE (0.38) NPSR1HRH3DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160031841-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS AXIKIN PHARMACEUTICALS, INC. 2016-02-04 — — US disclosed
US-9187425-B2 2,5-disubstituted arylsulfonamide CCR3 antagonists AXIKIN PHARMACEUTICALS, INC. (US) 2015-11-17 — — US disclosed
US-20140066446-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS AXIKIN PHARMACEUTICALS, INC. (US) 2014-03-06 — — US disclosed
US-8563544-B2 2,5-disubstituted arylsulfonamide CCR3 antagonists AXIKIN PHARMACEUTICALS, INC. (US) 2013-10-22 — — US disclosed
US-20130065889-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS AXIKIN PHARMACEUTICALS, INC. (US) 2013-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031841-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS CCR3, CCR1, CCR4 CHRNA7 947/4885L3MBTL1 2897/4885NPSR1 257/4885
US-20140066446-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS CCR3, CCR1, CCR4 CHRNA7 947/4885L3MBTL1 2897/4885NPSR1 257/4885
US-20130065889-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS CCR3, CCR1, CCR4 CHRNA7 947/4885L3MBTL1 2897/4885NPSR1 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.